Top NASDAQ Biotechnology Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1AZN AstraZeneca PLC ADR
54.07 B
 0.18 
 1.15 
 0.21 
2SNY Sanofi ADR
44.29 B
 0.16 
 1.37 
 0.23 
3AMGN Amgen Inc
33.42 B
 0.20 
 1.52 
 0.30 
4GILD Gilead Sciences
28.75 B
 0.22 
 1.58 
 0.34 
5GMAB Genmab AS
21.53 B
 0.00 
 2.82 
(0.01)
6VTRS Viatris
14.74 B
(0.21)
 2.44 
(0.51)
7REGN Regeneron Pharmaceuticals
14.2 B
(0.07)
 2.08 
(0.14)
8VRTX Vertex Pharmaceuticals
11.02 B
 0.27 
 1.48 
 0.39 
9BIIB Biogen Inc
9.68 B
(0.04)
 1.75 
(0.07)
10GRFS Grifols SA ADR
6.59 B
 0.01 
 2.73 
 0.02 
11ILMN Illumina
4.37 B
(0.28)
 2.75 
(0.77)
12INCY Incyte
4.24 B
(0.07)
 2.21 
(0.16)
13JAZZ Jazz Pharmaceuticals PLC
4.07 B
 0.03 
 1.80 
 0.06 
14MRNA Moderna
3.24 B
(0.04)
 5.41 
(0.19)
15UTHR United Therapeutics
2.88 B
(0.10)
 2.32 
(0.22)
16BMRN Biomarin Pharmaceutical
2.85 B
 0.12 
 1.63 
 0.19 
17AMRX Amneal Pharmaceuticals, Class
2.79 B
 0.05 
 2.07 
 0.11 
18BNTX BioNTech SE
2.75 B
(0.07)
 3.29 
(0.22)
19FTRE Fortrea Holdings
2.7 B
(0.28)
 4.32 
(1.21)
20NBIX Neurocrine Biosciences
2.36 B
(0.09)
 2.84 
(0.26)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.